Precision Medicine & Biomarkers 2018


On 29 & 30 November 2018, Beijing (China) will host the BioTech Pharma Summit: Precision Medicine & Biomarkers 2018 conference. This year’s event will bring together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the conference a perfect meeting-place to share experience, foster collaborations across industry and academia, evaluate emerging technologies and all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.

Attending this Summit will provide you with the opportunity to mix and interact with experts working in all facets of Precision Medicine through the individual, panel and roundtable discussions on offer. It is a Summit not to be missed.

The biomarkers market is projected to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016. Growth in the biomarkers market is mainly driven by factors such as increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research. On the other hand, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage are the major factors restraining the growth of this market.

The Precision Medicine & Biomarkers 2018 provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.


The BioTech Pharma Summit: Precision Medicine & Biomarkers 2018 will be focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials.


  • Identifying the most promising directions & preparing for the future of precision research
  • Innovation in Digital Health for Personalized healthcare
  • Data driven precision medicine – Improving the source & quality of data
  • Precision Medicine beyond oncology
  • Next generation clinical trials for Precision Medicine
  • Artificial Intelligence and machine learning
  • Fundamental Concepts in Biomarker Research
  • Advance Biomarker Research
  • Biomarkers in Health and Disease
  • Technologies in Biomarker Discover
  • Predictive biomarkers
  • Immune checkpoint inhibitors / immune response monitoring
  • Liquid biopsies – clinical utility
  • Immuno-Oncology Biomarkers
  • Biomarker validation & qualification
  • Circulating Tumor Cells, Microvesicles, DNA and RNA – detection & monitoring
  • Biomarkers for Early Identification of Neurological Disease
  • Monitoring Progression and Treatment Efficacy using Biomarkers
  • Biomarker Patenting and Marketplace
  • Digital biomarkers
  • Clinical Trail Design
  • Mutation Analysis For Clinical Biomarkers and Diagnostics
  • Translational Biomarkers in Drug Development
  • Clinical biomarker discovery
  • Biomarker: Clinical Development & Clinical Trials
  • Developing successful Rx-Dx partnerships, integration and co-development
  • Molecular Diagnostics
  • Epidemiological Studies
  • Cancer Tissue Diagnostics
  • Overcoming CDx regulatory issues; updates/future developments & accelerating development
  • Successful CDx collaborations & approvals
  • Overcoming CDx challenges
  • CDx Reimbursement, market access & commercialization


The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

  • Assay Development
  • Biomarker Identification
  • Translational Medicine
  • Sample, Assay & Imaging Technologies
  • Vectorology & Biomarkers
  • Patient Stratification
  • Clinical Pathologist
  • Metabolic Profiling
  • PK/PD
  • Bioinformatics
  • Precision Medicine
  • Genomics & Molecular Biology
  • Rx/Dx co-development
  • Pharmacodynamics
  • Biomarkers Non-Clinical Safety
  • Biomarker Development
  • Quantitative Biomarkers & Biomeasures
  • Biobanking
Basic Package
Buy Ticket

Access to all Sessions

Access to all Networking Sessions

Cocktail Reception Included

Premium Package
Buy Ticket

Unique one-on-one meetings

Airport pick-up/drop-off

2 nights at the Hotel Venue

Basic Exhibition Package
Buy Ticket

3m2 exhibition space

1 Complementary ticket

25% discount for extra ticket

Premium Exhibition Package
Buy Ticket

6m2 exhibition space

1 Complementary ticket

2 nights at the Hotel Venue